Trump administration awarded XpresTest $40m in disease screening contracts

Questions about this coverage

How did the left and right cover Trump administration awarded XpresTest $40m in disease screening…?

Of the 6 outlets on this story carrying a published leaning rating, 83% are rated left, 17% are rated centre, 0% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 7. The sections above set out what each side emphasised, in its own terms.

Is Trump administration awarded XpresTest $40m in disease screening… left or right?

Too few of the outlets on this story carry a published leaning rating to say. 6 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.

Is the coverage of Trump administration awarded XpresTest $40m in disease screening… biased?

Trump administration awarded XpresTest $40m in disease screening contracts is one event reported by 7 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.

Which side is not reporting Trump administration awarded XpresTest $40m in disease screening…?

When we first saw this story, outlets rated right had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.

Which outlets covered Trump administration awarded XpresTest $40m in disease screening…?

7 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.

What federal contracts did XpresTest receive?

The Trump administration awarded XpresTest nearly $40 million in federal contracts. These contracts are for screening for Ebola and other infectious diseases, including one for screening at U.S. airports and another for responding to disease outbreaks in the Democratic Republic of Congo.

When were the contracts awarded in relation to the Trump family's involvement?

The contracts were awarded months after a firm linked to President Donald Trump’s elder sons invested in XpresTest’s parent company, XWELL. This timing was highlighted in the reporting.

What is XpresTest's experience with disease screening?

XpresTest has experience monitoring for COVID-19 at U.S. airports. However, reports indicate it has not previously worked with Ebola or biosecurity services abroad. Its parent company, XWELL, also sells spa treatments.